AI assistant
JOHNSON & JOHNSON — Director's Dealing 2022
Feb 16, 2022
29750_dirs_2022-02-15_ba2c7f52-42ec-41a1-8a0f-e9d7934f29aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2022-02-14
Reporting Person: McEvoy Ashley (EVP, WW Chair, Medical Devices)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-14 | Common Stock | M | 2885.0000 | $0.0000 | Acquired | 33040.9545 | Direct |
| 2022-02-14 | Common Stock | F | 792.0000 | $168.8500 | Disposed | 32248.9545 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-14 | Restricted Share Units | $ | M | 2885.0000 | Disposed | Common Stock (2885.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2607.0000 | Indirect |
| Common Stock | 300.0000 | Indirect |
Footnotes
F1: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).
F4: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).